the GI difference held for me right up to 15, which isnt what a couple of people here found
#tirzepatide 2026-02-02
Monday19 messages6 participantstimes are UTC
Highlights from this day
Assay note: BCH lot G-0641 reported at 98.6% of label content.
🧊7
at 2.5 my appetite went completely and i dropped back a step, eating nothing isnt a win
unrelated but no gap when i switched, took the last semaglutide dose and started this a week later
plateaued at 23 weeks the same way i did on semaglutide, so i doubt its compound specific
licensed top is 15 weekly, past that is not a licensed dose and nobody here can tell you what it does
*week 12 not week 2
5 was where i first noticed it properly, 2.5 did almost nothing for me
*2ml not 2.5
SURMOUNT-1 versus SURPASS-2, which one was the weight trial
📉1🤝5
at 1 my appetite is gone entirely, did anyone go down rather than up
i sat at 7.5 for 10 months and never needed more, which is where the folklore comes from
restarted at 2.5 after 13 months off and the first two doses reminded me why titration exists
i went to 15 and came back to 10, more suppression wasnt more useful for me
15 is the top
✅3👍1👀3
same plateau here
sorry to jump in is the sweet spot argument about effect or about side effects
👀1
at 15 the GI came back for me, so my easier profile claim only applies below that
back after 10 months, do i restart at 2.5 or pick up near where i left off